Bridged Bicyclo Compounds, Heterocyclic < Bromocriptine < Bromodeoxyuridine

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 28.
[0-20] [0 - 20][0 - 28][20-27][20-40]

Ident.	Authors (with country if any)	Title
000013 (1998)		Ropinirole: new preparation. Wait for more convincing data.
000064 (1999)	J L Montastruc [France] ; O. Rascol ; J M Senard	Treatment of Parkinson's disease should begin with a dopamine agonist.
000074 (1999)	S. Champagne [France] ; E. Coste ; H. Peyrière ; J. Nigond ; E. Mania ; M. Pons ; D. Hillaire-Buys ; P. Balmes ; J P Blayac ; J M Davy	Chronic constrictive pericarditis induced by long-term bromocriptine therapy: report of two cases.
000191 (2001)	J L Montastruc [France] ; K. Desboeuf ; M. Lapeyre-Mestre ; J M Senard ; O. Rascol ; C. Brefel-Courbon	Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease.
000199 (2000)		Pergolide and Parkinson's disease: new preparation. No clear benefit.
000282 (????)	Jacques Serratrice [France] ; Patrick Disdier ; Gilbert Habib ; François Viallet ; Pierre-Jean Weiller	Fibrotic valvular heart disease subsequent to bromocriptine treatment.
000422 (1992)	G. Durrieu [France] ; M E Llau ; O. Rascol ; J M Senard ; A. Rascol ; J L Montastruc	Parkinson's disease and weight loss: a study with anthropometric and nutritional assessment.
000517 (2005)		Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
000584 (2006)	Djamel Ben Smaïl [France] ; Christiane Samuel ; Karine Rouy-Thenaisy ; Joelle Régnault ; Philippe Azouvi	Bromocriptine in traumatic brain injury.
000601 (1991)	D. Milon [France] ; H. Allain ; D. Bentue-Ferrer ; J P Martinet ; M H Lemaitre ; R. Decombe	Cardiac beta-adrenoceptor sensitivity and Parkinson's disease.
000720 (1991)	H. Allain [France] ; F. Le Coz ; F. Goulley ; F. Brunet-Bourgin ; Y. Loria ; D. Bentue-Ferrer ; R. Decombe ; J M Reymann ; P. Chaumet-Riffaud ; J M Gandon	Comparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians: a randomized double-blind crossover study.
000967 (2009)	Joëlle Micallef [France] ; Marc Rey [France] ; Alexandre Eusebio [France] ; Christine Audebert [France] ; Frank Rouby [France] ; Elisabeth Jouve [France] ; Sophie Tardieu [France] ; Oliver Blin [France]	Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects
000A47 (2009)	Sarah Vautier [France] ; Aline Milane ; Christine Fernandez ; Helene Chacun ; Lucette Lacomblez ; Robert Farinotti	Role of two efflux proteins, ABCB1 and ABCG2 in blood-brain barrier transport of bromocriptine in a murine model of MPTP-induced dopaminergic degeneration.
000B36 (1991)	G. Durrieu [France] ; J M Senard ; M A Tran ; A. Rascol ; J L Montastruc	Effects of levodopa and bromocriptine on blood pressure and plasma catecholamines in parkinsonians.
000C38 (1990)	D. Milon [France] ; H. Allain ; J M Reymann ; G. Morel ; O. Sabouraud ; J. Van Den Driessche	Randomized double-blind trial of injectable heptaminol for controlling spontaneous or bromocriptine-induced orthostatic hypotension in parkinsonians.
001162 (2014)	Thomas Cautres [France] ; Michel Cautres [France] ; Dania Mohty [France]	Multiple valvular regurgitation associated with bromocriptine therapy.
001285 (2014)	Omar Ouachikh [France] ; Wisam Dieb [France] ; Franck Durif [France] ; Aziz Hafidi [France]	Anterior ventral tegmental area dopaminergic neurons are not involved in the motivational effects of bromocriptine, pramipexole and cocaine in drug-free rats.
001890 (1989)	J L Montastruc ; O. Rascol ; A. Rascol	A randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients: a 3 year follow-up.
001C41 (1988)	D. Bentué-Ferrer [France] ; H. Allain ; J M Reymann ; O. Sabouraud ; J. Van Den Driessche	Lack of pharmacokinetic influence on levodopa by bromocriptine.
001C46 (1987)	J L Montastruc [France] ; P. Celsis ; A. Agniel ; J F Demonet ; B. Doyon ; M. Puel ; J P Marc-Vergnes ; A. Rascol	Levodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease. Lack of correlation with clinical or neuropsychological improvements.
001D06 (1994)	O. Rascol [France] ; N. Fabre ; O. Blin ; J. Poulik ; U. Sabatini ; J M Senard ; M. Ané ; J L Montastruc ; A. Rascol	Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Bromocriptine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Bromocriptine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Bromocriptine
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024